|
Market Closed -
Nasdaq
16:00:00 2026-10-30 EDT
|
5-day change | 1st Jan Change | ||
| 652.01 USD | -3.77% |
|
-2.57% | +16.09% |
| 10-28 | Medpace Holdings Insider Sold Shares Worth $13,540,000, According to a Recent SEC Filing | MT |
| 10-23 | Medpace's Bookings, Pre-Backlog Trends Support Growth Outlook, UBS Says | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 18.95B | |||||
| 64.38B | |||||
| 56.16B | |||||
| 54.16B | |||||
| 45.33B | |||||
| 42.25B |
Select your edition
All financial news and data tailored to specific country editions
